Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026)
Enovis' (ENOV) quarterly Liabilities and Shareholders Equity came in at $3.8 billion in Q3 2026, down 25.0% year-over-year from $5.0 billion in Q3 2025, and down 1.73% quarter-over-quarter from $3.8 billion in Q2 2026.
Analysis
Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $3.8 billion the latest figure, recorded in Q3 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 25.0% year-over-year to $3.8 billion in Q3 2026; TTM through Jul 2026 was $15.9 billion, a 21.32% decrease from a year earlier, with the FY2025 full-year figure at $3.8 billion, down 18.73% from the prior year.
- Liabilities and Shareholders Equity was $3.8 billion for Q3 2026 at Enovis, down from $3.8 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $8.5 billion in Q2 2022 and troughed at $3.8 billion in Q3 2026.
- A 5-year average of $4.8 billion and a median of $4.5 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity tumbled 49.82% in 2022 and rose 27.42% in 2024, its largest moves.
- Over 5 years, Liabilities and Shareholders Equity stood at $4.3 billion in 2022, then increased by 5.52% to $4.5 billion in 2023, then climbed by 4.64% to $4.7 billion in 2024, then fell by 18.73% to $3.8 billion in 2025, then fell by 1.79% to $3.8 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $3.8 billion (Q3 2026), $3.8 billion (Q2 2026), and $3.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 126.56 Bn | 121.34 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 118.15 Bn | 109.33 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 104.94 Bn | 101.46 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 32.07 Bn | 30.13 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 20.78 Bn | 20.29 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn | 3.77 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 3.77 Bn |
| Apr 3, 2026 | 3.83 Bn |
| Dec 31, 2025 | 3.83 Bn |
| Oct 3, 2025 | 4.43 Bn |
| Jul 4, 2025 | 5.02 Bn |
| Apr 4, 2025 | 4.88 Bn |
| Dec 31, 2024 | 4.72 Bn |
| Sep 27, 2024 | 5.55 Bn |
| Jun 28, 2024 | 5.44 Bn |
| Mar 29, 2024 | 5.48 Bn |
| Dec 31, 2023 | 4.51 Bn |
| Sep 29, 2023 | 4.40 Bn |
| Jun 30, 2023 | 4.44 Bn |
| Mar 31, 2023 | 4.30 Bn |
| Dec 31, 2022 | 4.27 Bn |
| Sep 30, 2022 | 4.44 Bn |
| Jul 1, 2022 | 4.50 Bn |
| Apr 1, 2022 | 8.48 Bn |
| Dec 31, 2021 | 8.52 Bn |
| Oct 1, 2021 | 7.97 Bn |